Jörg Gierds, Fette Compacting, says that training of tablet press operators will help manufacturers stay on the right side of the US Food and Drug Administration (FDA)
John Welch, Butterworth Laboratories, urges pharmaceutical manufacturers to prepare sooner rather than later for the impending changes to elemental impurities requirements
Scientists have identified that glucose fuels the growth of cancer. The particular protein that fuels this growth is PARP14. They hope to create a drug which inhibits PARP 14, starves the cancerous cells and, in the future, can be used to cure cancer
Capsugel’s Steven Facer says prioritisation of quality and regulatory compliance from the start is key to achieving long-term gains for emerging markets